Prostate cancer is a common cancer among men in America and is a leading cause of cancer deaths. Prostate cancer screening aids in catching cancer early on, when it is much easier to cure.
A prostate cancer screening typically consists of a PSA blood test or Digital Rectal Exam (DRE). A PSA blood test examines the level of prostate-specific antigens in the blood, while the DRE physically examines the prostate for abnormal areas.
If tests return indicating an abnormality, your physician will likely suggest an ultrasound or perform a prostate biopsy in which small pieces of tissue are tested in a lab.
Prostate cancer is typically considered treatable if discovered while still isolated in the prostate gland. Patients seldom have symptoms in the early stages of prostate cancer, making a prostate cancer screening an important factor in a patient’s continued health or treatment process.
If you are a male of at least 40 years of age or older, you should speak with a physician to discuss your risk for prostate cancer. You are at a greater risk of developing prostate cancer if you have a family history of the disease, are African American, or are above the age of 50.